The global Sunitinib Malate Market is witnessing steady expansion as the demand for targeted cancer therapies continues to rise. According to the Sunitinib Malate Market Report, the market was valued at USD 105.22 million in 2022 and is projected to reach USD 278.54 million by 2032, growing at a CAGR of 10.60% during the forecast period. This growth reflects the increasing reliance on precision...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek